<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.6.1.5240
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-weight: bold;">As filed with the Securities and Exchange Commission on July 26, 2024</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-______</div>
    <div>&#160;
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div>&#160;</div>
    <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM S-8</div>
    <div style="text-align: center; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; font-weight: bold;">UNDER THE SECURITIES ACT OF 1933</div>
    <div><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold;">ROIVANT SCIENCES LTD.</div>
    <div style="text-align: center; color: rgb(0, 0, 0);">(Exact name of registrant as specified in its charter)</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z8d1398367af0466d8aaf189b1f7ec43f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Bermuda</div>
          </td>
          <td style="width: 1.7%; vertical-align: middle;">&#160;</td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">98-1173944</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; color: rgb(0, 0, 0);">(State or other jurisdiction of incorporation or organization)</div>
          </td>
          <td style="width: 1.7%; vertical-align: middle;">&#160;</td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; color: rgb(0, 0, 0);">(I.R.S. Employer Identification No.)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">7th Floor</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">50 Broadway</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">London SW1H 0DB</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">United Kingdom</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Telephone: +44 207 400 3347</div>
    <div style="text-align: center; margin-left: 1.25pt; color: rgb(0, 0, 0);">(Address of Principal Executive Offices)</div>
    <div>&#160;</div>
    <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; color: rgb(0, 0, 0); font-weight: bold;">ROIVANT SCIENCES LTD. 2021 EQUITY INCENTIVE PLAN</div>
    <div style="text-align: center; color: rgb(0, 0, 0);">(Full Title of the Plan)</div>
    <div>&#160;</div>
    <div style="text-align: center; margin-right: 0.15pt; margin-left: 0.15pt; color: #000000; font-weight: bold;">Corporation Service Company</div>
    <div style="text-align: center; margin-right: 0.15pt; margin-left: 0.15pt; color: #000000; font-weight: bold;">251 Little Falls Drive</div>
    <div style="text-align: center; margin-right: 0.15pt; margin-left: 0.15pt; color: #000000; font-weight: bold;">Wilmington, DE 19808</div>
    <div style="text-align: center; margin-right: 0.15pt; margin-left: 1.25pt; color: #000000; font-weight: bold;">Telephone: (800) 927-9801</div>
    <div style="text-align: center; color: rgb(0, 0, 0);">(Name and Address for Agent of Service)</div>
    <div style="text-align: center; color: rgb(0, 0, 0);">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"> </div>
    <div style="text-align: center; margin-left: 1.25pt; color: rgb(0, 0, 0);">(Telephone number, Including Area Code, of Agent For Service)</div>
    <div>&#160;</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Copies of all correspondence to:</div>
    <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Derek J. Dostal</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Stephen A. Byeff</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Davis Polk &amp; Wardwell LLP</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">450 Lexington Avenue</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">New York, NY 10017</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(212) 450-4000</div>
    <div style="text-align: center; margin-left: 18pt; color: #000000; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; margin-left: 18pt; color: #000000; font-weight: bold;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 22%; color: #000000;"> </div>
    <div style="text-align: center; margin-left: 18pt; color: #000000; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large
      accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z6ac5157550094719ae491499dccb469d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 32.93%; vertical-align: top;">
            <div style="color: #000000;">Large accelerated filer &#9745;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 22%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); text-align: right;">Accelerated filer&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 32.93%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Non-accelerated filer&#160;&#160; &#9744;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 22%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); text-align: right;">Smaller reporting company &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 32.93%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 22%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); text-align: right;">Emerging growth company &#9744;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the
      Securities Act. &#9744;</div>
    <div> <br>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">EXPLANATORY NOTE</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">REGISTRATION OF ADDITIONAL SHARES</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">PURSUANT TO GENERAL INSTRUCTION E</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Pursuant to General Instruction E to Form S-8, the Registrant is filing this Registration Statement with the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) to register additional shares
      of the Registrant&#8217;s Common Stock for issuance under the Roivant Sciences Ltd. 2021 Equity Incentive Plan (the &#8220;Plan&#8221;), pursuant to the provision of the Plan that provides for automatic annual increases in the number of shares reserved for issuance
      thereunder. This Registration Statement hereby incorporates by reference the contents of the Registrant&#8217;s registration statement on Form S-8 filed with the Commission on October 8, 2021 (File No. 333-260173), the registration statement on Form S-8
      filed with the Commission on June 28, 2022 (File No. 333-265867) and the registration statement on Form S-8 filed with the commission on June 29, 2023 (File No. 333-273000), to the extent not superseded hereby.</div>
    <div>&#160;</div>
    <div style="text-align: center; text-indent: 18pt; font-weight: bold;">PART I</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The documents containing the information specified in Item 1 and Item 2 of Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act of 1933, as
      amended (the &#8220;Securities Act&#8221;). In accordance with the rules and regulations of the Commission and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses
      or prospectus supplements pursuant to Rule 424 under the Securities Act.</div>
    <div>&#160;</div>
    <div style="text-align: center; text-indent: 18pt; font-weight: bold;">PART II</div>
    <div>&#160;</div>
    <div style="text-align: center; text-indent: 18pt; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za5a1bf2c82344e5e82c56896640ff4c4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 3.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">Incorporation of Documents by Reference.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>The following documents are incorporated herein by reference:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 18pt;">(a) the Company&#8217;s annual report on Form 10-K for the fiscal year ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1635088/000114036124028145/ef20026301_10k.htm">March 31, 2024</a>,
      filed with the Commission May 30, 2024 (File No. 001-40782) (the &#8220;Annual Report&#8221;), including the sections of the Registrant&#8217;s Definitive Proxy Statement on Schedule 14A for the Registrant&#8217;s 2024 Annual General Meeting of Shareholders, as filed with
      the Commission on <a href="https://www.sec.gov/Archives/edgar/data/1635088/000114036124034423/ny20026685x1_def14a.htm">July 26, 2024</a>, incorporated by reference in the Annual Report;</div>
    <div>&#160;</div>
    <div style="text-indent: 18pt;">(b) all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Company&#8217;s Annual Report referred to in (a) above; and</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 18pt;">(c) The description of the Company&#8217;s securities registered pursuant to Section 12 of the Exchange Act (<a href="https://www.sec.gov/Archives/edgar/data/1635088/000114036123031798/brhc20054745_ex4-5.htm">filed as Exhibit 4.5 to the Company&#8217;s Annual Report</a>).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 18pt;">All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, after the date of this Registration Statement and prior to the filing of a post-effective
      amendment that indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, are incorporated by reference in this Registration Statement and are a part hereof from the date of filing of such
      documents; except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under current Items 2.02 or 7.01 of Form 8-K that is not deemed filed under such provisions. Any statement contained
      in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed
      document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this
      Registration Statement.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z43abf3fc0ec74f9398278f01da6189e0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 8.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">Exhibits.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z9fec646b4bc5438c99ee7a977d9a8d57" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div>Exhibit Number</div>
            </div>
          </td>
          <td style="width: 2%; vertical-align: top;" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: top;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">
            <div>3.1</div>
          </td>
          <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);" rowspan="1">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1635088/000119312521205193/d65062dex31.htm">Memorandum of Association of Roivant Sciences Ltd. (incorporated herein by reference to Exhibit 3.1 to the
                Registrant&#8217;s Registration Statement on Form S-4/A (File No. 333-256165), as amended, filed with the Commission on May 14, 2021)</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: bottom;" rowspan="1" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: bottom;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.2</div>
          </td>
          <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1635088/000119312521288885/d230641dex31.htm">Amended and Restated Bye-laws of Roivant Sciences Ltd. (incorporated herein by reference to Exhibit 3.1 to the
                Registrant&#8217;s Current Report on Form 8-K (File No. 001-40782), filed with the Commission on October 1, 2021)</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: bottom;" rowspan="1" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: bottom;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>5.1*</div>
          </td>
          <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; color: #000000;"><a href="ef20032883_ex5-1.htm">Opinion of Conyers Dill &amp; Pearman Limited</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: top;" rowspan="1" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>23.1*</div>
          </td>
          <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; color: rgb(0, 0, 0);"><a href="ef20032883_ex23-1.htm">Consent of Ernst &amp; Young LLP</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: top;" rowspan="1" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>23.2*</div>
          </td>
          <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; color: rgb(0, 0, 0);"><a href="ef20032883_ex5-1.htm">Consent of Conyers Dill &amp; Pearman Limited (included in Exhibit
                5.1)</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: top;" rowspan="1" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>24.1*</div>
          </td>
          <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; color: rgb(0, 0, 0);"><a href="#POWEROFATTORNEY">Power of Attorney (included on the signature page hereto)</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: bottom;" rowspan="1" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: bottom;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>99.1</div>
          </td>
          <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1635088/000095010321015700/dp159512_ex9901.htm">Roivant Sciences Ltd. 2021 Equity Incentive Plan (incorporated herein by reference to Exhibit 99.1 to the
                Registrant&#8217;s Registration Statement on Form S-8 (File No. 333-260173), filed with the Commission on October 8, 2021)</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: middle;" rowspan="1" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: middle;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>107.1*</div>
          </td>
          <td style="width: 2%; vertical-align: middle; background-color: rgb(204, 238, 255);" colspan="1"><br>
          </td>
          <td style="width: 90%; vertical-align: middle; background-color: rgb(204, 238, 255);">
            <div><a href="ef20032883_ex107-1.htm">Filing Fee Table</a></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div>* <font style="color: rgb(0, 0, 0);">Filed herewith</font></div>
      <div><font style="color: rgb(0, 0, 0);"> <br>
        </font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; color: #000000;">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
      S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Oxford, UK, on the 26th day of July 2024.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zec736d69e45d48b58cc2b2f3f7393e2a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="color: rgb(0, 0, 0);">ROIVANT SCIENCES LTD.</div>
          </td>
          <td style="vertical-align: top; width: 10%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="vertical-align: top;" colspan="2">&#160;</td>
          <td rowspan="1" style="vertical-align: top; width: 10%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
            <div>By:</div>
          </td>
          <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">/s/ Matt Maisak</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>Name:</div>
          </td>
          <td style="width: 35%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Matt Maisak</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>Title:</div>
          </td>
          <td style="width: 35%; vertical-align: top;">
            <div>Authorized Signatory</div>
          </td>
          <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="text-align: center;"><font style="font-weight: bold;"> </font><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">POWER OF ATTORNEY<a name="POWEROFATTORNEY"><!--Anchor--></a></div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 42.85pt; color: rgb(0, 0, 0);">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below, constitutes and appoints Richard Pulik, Jo Chen and Matthew Maisak and each or any one of
        them, our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, to do any and all acts and things and execute, in the name of the undersigned, any and all instruments which said attorneys-in-fact and
        agents may deem necessary or advisable in order to enable Roivant Sciences Ltd. to comply with the Securities Act of 1933, as amended, and any requirements of the Securities and Exchange Commission in respect thereof, in connection with the filing
        with the Securities and Exchange Commission of one or more registration statements on Form S-8 under the Securities Act of 1933, as amended, including, specifically, but without limitation, power and authority to sign the name of the undersigned to
        any such registration statement, and any amendments to any such registration statement (including post-effective amendments), and to file the same with all exhibits thereto and other documents in connection therewith, with the Securities and
        Exchange Commission, to sign any and all applications, registration statements, notices or other documents necessary or advisable to comply with applicable state securities laws, and to file the same, together with other documents in connection
        therewith with the appropriate state securities authorities, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and to perform each and every act and thing requisite or necessary to be done in and
        about the premises, as fully and to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and any of them, or their substitutes, may lawfully do or cause
        to be done by virtue hereof.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 42.85pt; color: #000000;">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates
        indicated.</div>
      <div>&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" id="z0458b7698d8b4a8f9a57ce594487e976" style="border-collapse: collapse; width: 80%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

        <tr>
          <td style="width: 20%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><u>Signature</u></div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><u>Title</u></div>
          </td>
          <td style="width: 15%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><u>Date</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: bottom;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 15%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Matthew Gline</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Chief Executive Officer &amp; Director</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Matthew Gline</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">(principal executive officer)</div>
          </td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Richard Pulik</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Chief Financial Officer</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center;">Richard Pulik</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">(principal financial officer)</div>
          </td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Rakhi Kumar</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Chief Accounting Officer</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Rakhi Kumar</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">(principal accounting officer)</div>
          </td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Keith Manchester</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">&#160;July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Keith Manchester</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Ilan Oren</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Ilan Oren</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Daniel Gold</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Daniel Gold</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Melissa Epperly</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Melissa Epperly</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Meghan FitzGerald</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Meghan FitzGerald</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ James C. Momtazee</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">James C. Momtazee</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Mayukh Sukhatme</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
          </td>
          <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">July 26, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">Mayukh Sukhatme</div>
          </td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
          <td style="width: 15%; vertical-align: bottom;">&#160;</td>
        </tr>

    </table>
    <div>&#160;</div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "ef20032883_s8.htm", "description": "S-8", "secsgml_size_bytes": 42909}]
{"company-data": {"conformed-name": "Roivant Sciences Ltd.", "cik": "0001635088", "assigned-sic": "2834", "organization-name": "03 Life Sciences", "irs-number": "981173944", "state-of-incorporation": "D0", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-281061", "film-number": "241148007"}, "business-address": {"street1": "CLARENDON HOUSE, 2 CHURCH STREET", "city": "HAMILTON HM11", "state": "D0", "zip": "HM11", "phone": "441-295-5950"}, "mail-address": {"street1": "CLARENDON HOUSE", "street2": "2 CHURCH STREET", "city": "HAMILTON", "state": "D0", "zip": "HM11"}}
As filed with the Securities and Exchange Commission on July 26, 2024
Registration No. 333-______
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
ROIVANT SCIENCES LTD.
(Exact name of registrant as specified in its charter)
Bermuda
98-1173944
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
7th Floor
50 Broadway
London SW1H 0DB
United Kingdom
Telephone: +44 207 400 3347
(Address of Principal Executive Offices)
ROIVANT SCIENCES LTD. 2021 EQUITY INCENTIVE PLAN
(Full Title of the Plan)
Corporation Service Company
251 Little Falls Drive
Wilmington, DE 19808
Telephone: (800) 927-9801
(Name and Address for Agent of Service)
(Telephone number, Including Area Code, of Agent For Service)
Copies of all correspondence to:
Derek J. Dostal
Stephen A. Byeff
Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, NY 10017
(212) 450-4000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large
      accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☑
Accelerated filer                  ☐
Non-accelerated filer   ☐
Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the
      Securities Act. ☐
EXPLANATORY NOTE
REGISTRATION OF ADDITIONAL SHARES
PURSUANT TO GENERAL INSTRUCTION E
Pursuant to General Instruction E to Form S-8, the Registrant is filing this Registration Statement with the U.S. Securities and Exchange Commission (the "Commission") to register additional shares
      of the Registrant's Common Stock for issuance under the Roivant Sciences Ltd. 2021 Equity Incentive Plan (the "Plan"), pursuant to the provision of the Plan that provides for automatic annual increases in the number of shares reserved for issuance
      thereunder. This Registration Statement hereby incorporates by reference the contents of the Registrant's registration statement on Form S-8 filed with the Commission on October 8, 2021 (File No. 333-260173), the registration statement on Form S-8
      filed with the Commission on June 28, 2022 (File No. 333-265867) and the registration statement on Form S-8 filed with the commission on June 29, 2023 (File No. 333-273000), to the extent not superseded hereby.
PART I
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
The documents containing the information specified in Item 1 and Item 2 of Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act of 1933, as
      amended (the "Securities Act"). In accordance with the rules and regulations of the Commission and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses
      or prospectus supplements pursuant to Rule 424 under the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference.
The following documents are incorporated herein by reference:
(a) the Company's annual report on Form 10-K for the fiscal year ended
March 31, 2024
,
      filed with the Commission May 30, 2024 (File No. 001-40782) (the "Annual Report"), including the sections of the Registrant's Definitive Proxy Statement on Schedule 14A for the Registrant's 2024 Annual General Meeting of Shareholders, as filed with
      the Commission on
July 26, 2024
, incorporated by reference in the Annual Report;
(b) all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Company's Annual Report referred to in (a) above; and
(c) The description of the Company's securities registered pursuant to Section 12 of the Exchange Act (
filed as Exhibit 4.5 to the Company's Annual Report
).
All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, after the date of this Registration Statement and prior to the filing of a post-effective
      amendment that indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, are incorporated by reference in this Registration Statement and are a part hereof from the date of filing of such
      documents; except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under current Items 2.02 or 7.01 of Form 8-K that is not deemed filed under such provisions. Any statement contained
      in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed
      document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this
      Registration Statement.
Item 8.
Exhibits.
Exhibit Number
3.1
Memorandum of Association of Roivant Sciences Ltd. (incorporated herein by reference to Exhibit 3.1 to the
                Registrant's Registration Statement on Form S-4/A (File No. 333-256165), as amended, filed with the Commission on May 14, 2021)
3.2
Amended and Restated Bye-laws of Roivant Sciences Ltd. (incorporated herein by reference to Exhibit 3.1 to the
                Registrant's Current Report on Form 8-K (File No. 001-40782), filed with the Commission on October 1, 2021)
5.1*
Opinion of Conyers Dill & Pearman Limited
23.1*
Consent of Ernst & Young LLP
23.2*
Consent of Conyers Dill & Pearman Limited (included in Exhibit
                5.1)
24.1*
Power of Attorney (included on the signature page hereto)
99.1
Roivant Sciences Ltd. 2021 Equity Incentive Plan (incorporated herein by reference to Exhibit 99.1 to the
                Registrant's Registration Statement on Form S-8 (File No. 333-260173), filed with the Commission on October 8, 2021)
107.1*
Filing Fee Table
*
Filed herewith
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
      S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Oxford, UK, on the 26th day of July 2024.
ROIVANT SCIENCES LTD.
By:
/s/ Matt Maisak
Name:
Matt Maisak
Title:
Authorized Signatory
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below, constitutes and appoints Richard Pulik, Jo Chen and Matthew Maisak and each or any one of
        them, our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, to do any and all acts and things and execute, in the name of the undersigned, any and all instruments which said attorneys-in-fact and
        agents may deem necessary or advisable in order to enable Roivant Sciences Ltd. to comply with the Securities Act of 1933, as amended, and any requirements of the Securities and Exchange Commission in respect thereof, in connection with the filing
        with the Securities and Exchange Commission of one or more registration statements on Form S-8 under the Securities Act of 1933, as amended, including, specifically, but without limitation, power and authority to sign the name of the undersigned to
        any such registration statement, and any amendments to any such registration statement (including post-effective amendments), and to file the same with all exhibits thereto and other documents in connection therewith, with the Securities and
        Exchange Commission, to sign any and all applications, registration statements, notices or other documents necessary or advisable to comply with applicable state securities laws, and to file the same, together with other documents in connection
        therewith with the appropriate state securities authorities, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and to perform each and every act and thing requisite or necessary to be done in and
        about the premises, as fully and to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and any of them, or their substitutes, may lawfully do or cause
        to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates
        indicated.
Signature
Title
Date
/s/ Matthew Gline
Chief Executive Officer & Director
July 26, 2024
Matthew Gline
(principal executive officer)
/s/ Richard Pulik
Chief Financial Officer
July 26, 2024
Richard Pulik
(principal financial officer)
/s/ Rakhi Kumar
Chief Accounting Officer
July 26, 2024
Rakhi Kumar
(principal accounting officer)
/s/ Keith Manchester
Director
July 26, 2024
Keith Manchester
/s/ Ilan Oren
Director
July 26, 2024
Ilan Oren
/s/ Daniel Gold
Director
July 26, 2024
Daniel Gold
/s/ Melissa Epperly
Director
July 26, 2024
Melissa Epperly
/s/ Meghan FitzGerald
Director
July 26, 2024
Meghan FitzGerald
/s/ James C. Momtazee
Director
July 26, 2024
James C. Momtazee
/s/ Mayukh Sukhatme
Director
July 26, 2024
Mayukh Sukhatme